Table 3. Cross sectional study: clinical characteristics of MH-NW, MHO and MUO subjects from SHOS.
| MH-NW (n = 132) | MHO (n = 107) | MUO (n = 73) | |
|---|---|---|---|
| Women (%) | 64 | 64 | 49 |
| Age (years) | 46 ± 10 | 46 ± 8 | 57 ± 7‡ |
| BMI (kg/m2) | 20.5 ± 0.7 | 27.1 ± 1.9** | 27.7 ± 2.6 |
| WC (cm) | 73 ± 5 | 88 ± 8** | 92 ± 7§‡ |
| SBP (mmHg) | 115 ± 11 | 116 ± 11 | 138 ± 22‡ |
| DBP (mmHg) | 72 ± 8 | 75 ± 8** | 82 ± 14‡ |
| FPG (mmol/L) | 5.0 ± 0.4 | 5.1 ± 0.4** | 8.0 ± 2.6‡ |
| 2hPG (mmol/L) | 5.6 ± 1.1 | 5.7 ± 1.0 | 14.9 ± 4.3‡ |
| HbA1c (%) | 5.4 ± 0.3 | 5.4 ± 0.4 | 7.1 ± 1.4§‡ |
| FINS (μU/mL) | 5.8 ± 2.6 | 9.1 ± 4.2 | 11.0 ± 5.2‡ |
| 2 h INS (μU/mL) | 27.8 ± 16.8 | 36.8 ± 24.0 | 69.7 ± 50.4‡ |
| TC (mmol/L) | 4.3 ± 0.6 | 4.3 ± 0.5 | 5.4 ± 1.0‡ |
| TG (mmol/L) | 0.8 ± 0.3 | 1.0 ± 0.3** | 2.4 ± 1.5‡ |
| HDL-c (mmol/L) | 1.6 ± 0.3 | 1.4 ± 0.3** | 1.3 ± 0.2‡ |
| LDL-c (mmol/L) | 2.5 ± 0.5 | 2.7 ± 0.4** | 3.3 ± 0.8‡ |
| HOMA-IR | 1.3 ± 0.6 | 2.1 ± 1.0** | 3.9 ± 2.0‡ |
| Matsuda ISI | 177 ± 113 | 114 ± 52** | 63 ± 26§‡ |
| SA/PA (C18:0/C16:0) | 0.99 ± 0.12 | 1.02 ± 0.10 | 0.85 ± 0.11‡ |
| OA/SA (C18:1 n9/C18:0) | 0.65 ± 0.31 | 0.56 ± 0.23* | 0.85 ± 0.30‡ |
| AA/DGLA (C20:4 n6/C20:3 n6) | 8.61 ± 1.69 | 8.58 ± 1.89 | 7.56 ± 2.07‡ |
Entries are mean ± SD. P values were calculated by means of the Mann-Whitney test for continuous variables and χ2 test for categorical variables, respectively. *P < 0.05, **P < 0.01 for the difference between MHO and MH-NW; †P < 0.05, ‡P < 0.01 between MHO and MUO.